title: Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection.
abstract: BACKGROUND
  Variant Creutzfeldt-Jakob disease (vCJD) is a neurodegenerative infectious disorder, characterized by a prominent accumulation of pathological isoforms of the prion protein (PrP(TSE)) in the brain and lymphoid tissues. Since the publication in the United Kingdom of four apparent vCJD cases following transfusion of red blood cells and one apparent case following treatment with factor VIII, the presence of vCJD infectivity in the blood seems highly probable. For effective blood testing of vCJD individuals in the preclinical or clinical phase of infection, it is considered necessary that assays detect PrP(TSE) concentrations in the femtomolar range.
  
  
  RESULTS
  We have developed a three-step assay that firstly captures PrP(TSE) from infected blood using a plasminogen-coated magnetic-nanobead method prior to its serial amplification via protein misfolding cyclic amplification (PMCA) and specific PrP(TSE) detection by western blot. We achieved a PrP(TSE) capture yield of 95% from scrapie-infected material. We demonstrated the possibility of detecting PrP(TSE) in white blood cells, in buffy coat and in plasma isolated from the blood of scrapie-infected sheep collected at the pre-clinical stage of the disease. The test also allowed the detection of PrP(TSE) in human plasma spiked with a 10(-8) dilution of vCJD-infected brain homogenate corresponding to the level of sensitivity (femtogram) required for the detection of the PrP(TSE) in asymptomatic carriers. The 100% specificity of the test was revealed using a blinded panel comprising 96 human plasma samples.
  
  
  CONCLUSIONS
  We have developed a sensitive and specific amplification assay allowing the detection of PrP(TSE) in the plasma and buffy coat fractions of blood collected at the pre-clinical phase of the disease. This assay represents a good candidate as a confirmatory assay for the presence of PrP(TSE) in blood of patients displaying positivity in large scale screening tests.
authors.affiliation: EFS-PyMed (Etablissement Français du Sang de Pyrénées Méditerranée), R&D TransDiag, Sécurité Transfusionnelle et Innovation Diagnostique, Montpellier, France.
authors.forename: Christiane
authors.initials: C
authors.lastname: Segarra
authors.forename: Daisy
authors.initials: D
authors.lastname: Bougard
authors.forename: Mohammed
authors.initials: M
authors.lastname: Moudjou
authors.forename: Hubert
authors.initials: H
authors.lastname: Laude
authors.forename: Vincent
authors.initials: V
authors.lastname: Béringue
authors.forename: Joliette
authors.initials: J
authors.lastname: Coste
mesh_terms: D001681:Biological Assay / Q000379:methods*; D007562:Creutzfeldt-Jakob Syndrome / Q000097:blood*; D006801:Humans; D010958:Plasminogen / Q000737:chemistry*; D011328:Prions / Q000097:blood*
chemical_list: D011328:Prions; D010958:Plasminogen
references.citation: PLoS One. 2008 Jan 09;3(1):e1419
references.pmid: 18183299
references.citation: Nat Med. 2005 Sep;11(9):982-5
references.pmid: 16127436
references.citation: Methods Enzymol. 1998;295:127-49
references.pmid: 9750217
references.citation: Science. 2012 Jan 27;335(6067):411-3
references.pmid: 22282797
references.citation: Nature. 2001 Jun 14;411(6839):810-3
references.pmid: 11459061
references.citation: Nature. 1992 Apr 16;356(6370):577-82
references.pmid: 1373228
references.citation: PLoS One. 2010 Jan 19;5(1):e8765
references.pmid: 20098730
references.citation: Methods Enzymol. 2006;412:3-21
references.pmid: 17046648
references.citation: J Lab Clin Med. 2001 Jan;137(1):5-13
references.pmid: 11150018
references.citation: Lancet. 2001 Jun 23;357(9273):2026-8
references.pmid: 11438139
references.citation: Nat Rev Microbiol. 2004 Oct;2(10):809-19
references.pmid: 15378045
references.citation: Chem Rev. 2005 Apr;105(4):1547-62
references.pmid: 15826019
references.citation: PLoS One. 2010 Dec 23;5(12):e15626
references.pmid: 21203419
references.citation: Blood. 2008 Dec 1;112(12):4739-45
references.pmid: 18647958
references.citation: C R Biol. 2002 Jan;325(1):49-57
references.pmid: 11862622
references.citation: PLoS Pathog. 2011 Feb 10;7(2):e1001277
references.pmid: 21347353
references.citation: FEBS J. 2009 May;276(10):2841-8
references.pmid: 19459939
references.citation: Nature. 2000 Nov 23;408(6811):479-83
references.pmid: 11100730
references.citation: Prion. 2009 Jul-Sep;3(3):171-83
references.pmid: 19823039
references.citation: J Virol. 2011 Jul;85(13):6309-18
references.pmid: 21525361
references.citation: J Biol Chem. 2006 Nov 17;281(46):35245-52
references.pmid: 16982620
references.citation: J Pathol. 2007 Sep;213(1):21-6
references.pmid: 17614097
references.citation: Science. 2006 Jul 7;313(5783):92-4
references.pmid: 16825570
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
references.pmid: 9811807
references.citation: Nat Methods. 2010 Jul;7(7):519-20
references.pmid: 20512142
references.citation: Lancet. 2011 Feb 5;377(9764):487-93
references.pmid: 21295339
references.citation: Biochemistry. 2002 Jun 4;41(22):6891-6
references.pmid: 12033920
references.citation: PLoS One. 2012;7(7):e42019
references.pmid: 22860049
references.citation: Transfusion. 2009 Feb;49(2):376-84
references.pmid: 18980616
references.citation: Biochim Biophys Acta. 2003 Jul 30;1649(2):127-39
references.pmid: 12878031
references.citation: Nature. 1997 Oct 2;389(6650):498-501
references.pmid: 9333239
references.citation: Transfusion. 2010 May;50(5):996-1002
references.pmid: 20180925
references.citation: Vox Sang. 2012 Feb;102(2):100-9
references.pmid: 22126309
references.citation: J Virol. 2012 Feb;86(4):2056-66
references.pmid: 22156536
references.citation: Transfusion. 2002 May;42(5):513-6
references.pmid: 12084158
references.citation: J Gen Virol. 2008 Dec;89(Pt 12):3177-3184
references.pmid: 19008409
references.citation: FEBS Lett. 2005 Jan 31;579(3):638-42
references.pmid: 15670821
references.citation: BMC Biotechnol. 2007 Jul 20;7:43
references.pmid: 17659071
references.citation: PLoS One. 2011;6(8):e23169
references.pmid: 21858015
references.citation: FASEB J. 2010 Dec;24(12):5102-12
references.pmid: 20732953
references.citation: J Biol Chem. 2001 Apr 6;276(14):10577-80
references.pmid: 11279227
references.citation: Neurobiol Dis. 2011 Jan;41(1):219-25
references.pmid: 20875860
references.citation: PLoS One. 2009 Jun 04;4(6):e5796
references.pmid: 19495414
references.citation: Biochem Biophys Res Commun. 2003 Jun 6;305(3):518-22
references.pmid: 12763023
references.citation: PLoS Pathog. 2012;8(6):e1002782
references.pmid: 22737075
references.citation: Proteins. 2005 Feb 15;58(3):728-34
references.pmid: 15609351
references.citation: PLoS Pathog. 2010 Apr 15;6(4):e1000859
references.pmid: 20419156
references.citation: mBio. 2011 May 10;2(3):e00078-11
references.pmid: 21558432